Identifying the risks of anticoagulation in patients with substance abuse
about
Alcohol misuse, genetics, and major bleeding among warfarin therapy patients in a community setting.Capsule commentary on Efird et al., identifying the risks of anticoagulation in patients with substance abuse.Population attributable fractions of risk factors for hepatocellular carcinoma in the United States.Predictive Validity of Clinical AUDIT-C Alcohol Screening Scores and Changes in Scores for Three Objective Alcohol-related Outcomes in a Veterans Affairs (VA) Population.Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: A population-based study in SEER-Medicare.
P2860
Identifying the risks of anticoagulation in patients with substance abuse
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 26 April 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Identifying the risks of anticoagulation in patients with substance abuse
@en
Identifying the risks of anticoagulation in patients with substance abuse.
@nl
type
label
Identifying the risks of anticoagulation in patients with substance abuse
@en
Identifying the risks of anticoagulation in patients with substance abuse.
@nl
prefLabel
Identifying the risks of anticoagulation in patients with substance abuse
@en
Identifying the risks of anticoagulation in patients with substance abuse.
@nl
P2093
P2860
P1476
Identifying the risks of anticoagulation in patients with substance abuse
@en
P2093
Adam J Rose
Al Ozonoff
Arlene S Ash
Dan R Berlowitz
Donald R Miller
Guneet K Jasuja
Joel I Reisman
Lydia M Efird
Shibei Zhao
P2860
P2888
P304
P356
10.1007/S11606-013-2453-X
P577
2013-04-26T00:00:00Z